CODX vs MCK · rev $3.9M vs P/E 20, rev $403.43B
Co-Diagnostics, Inc. Common Stock (CODX) versus McKesson Corporation (MCK) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
CODX currently screens at market cap $31.4M. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Not investment advice. Open the CODX and MCK stock pages for the full models.
Not investment advice.